Maternal immunization downregulates offspring TCD4 regulatory cells (Tregs) thymic maturation without implications for allergy inhibition

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, v.88, n.6, article ID UNSP e12721, 8p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The regulation of offspring allergy development mediated by maternal immunization was evidenced by several groups, and this mechanism seems to involve the induction of regulatory T cells (Tregs) on offspring. Here, we aimed to evaluate whether the effect of maternal immunization on offspring Tregs occurs as a result of peripheral or central modulation. Briefly, C57BL/6 female mice were immunized with OVA in Alum or Alum alone and boosted with OVA in saline or saline only after 10 and 20 days. Non-immunized offspring serum, thymus and spleen were evaluated at 3 or 20 days old, and some groups of pups were submitted to neonatal OVA-immunization protocol for the subsequent evaluation of antibody production and allergic response. Our experimental protocol could be validated because maternal OVA-immunization inhibited offspring allergic response as evidenced by the suppression of offspring IgE production and allergic lung inflammation. Interestingly, maternal immunization reduced the frequency of offspring thymic Tregs with an opposite effect on spleen Tregs. Furthermore, after neonatal immunization, the frequency of lung-infiltrated Tregs was also augmented on offspring from immunized mothers. In conclusion, maternal OVA-immunization can inhibit the thymic maturation of offspring Tregs without implications on peripheral Tregs induction and allergy inhibition.
Palavras-chave
allergy, maternal immunization, thymus, Treg cells
Referências
  1. Ali HHM, 2017, IMMUNOL LETT, V185, P56, DOI 10.1016/j.imlet.2017.03.007
  2. Bacher P, 2016, CELL, V11
  3. BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x
  4. Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284
  5. Cupedo T, 2005, EUR J IMMUNOL, V35, P383, DOI 10.1002/eji.200425763
  6. Sgnotto FD, 2017, HUM VACC IMMUNOTHER, V13, P1563, DOI 10.1080/21645515.2017.1299299
  7. Lira AAD, 2018, ALLERGOL IMMUNOPATH, V46, P454, DOI 10.1016/j.aller.2018.04.001
  8. Lira AAD, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-47
  9. de Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8
  10. Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199
  11. Ellertsen LK, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-8
  12. Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865
  13. Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x
  14. Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x
  15. Hubeau C, 2006, AM J PATHOL, V168, P1931, DOI 10.2353/ajpati.7.2006.051231
  16. Itoh M, 1999, J IMMUNOL, V162, P5317
  17. Joetham A, 2008, J IMMUNOL, V180, P7117, DOI 10.4049/jimmunol.180.11.7117
  18. Joetham A, 2017, J ALLERGY CLIN IMMUN, V139, P1331, DOI 10.1016/j.jaci.2016.06.051
  19. Kong N, 2012, ARTHRITIS RHEUM-US, V64, P2548, DOI 10.1002/art.34513
  20. Li JZ, 2011, J NEUROIMMUNOL, V234, P109, DOI 10.1016/j.jneuroim.2011.03.008
  21. Martin-Orozco E, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00117
  22. Matson AP, 2007, J IMMUNOL, V179, P1282, DOI 10.4049/jimmunol.179.2.1282
  23. Mondoulet L, 2018, Allergy, DOI 10.1111/all.13479
  24. Morlacchi S, 2011, BLOOD, V118, P984, DOI 10.1182/blood-2011-02-336115
  25. Mukherjee Manali, 2018, Allergy Asthma Immunol Res, V10, P428, DOI 10.4168/aair.2018.10.5.428
  26. Muniz BP, 2014, IMMUNOBIOLOGY, V219, P377, DOI 10.1016/j.imbio.2014.01.002
  27. Nakashima T, 2014, INFLAMMATION, V37, P1642, DOI 10.1007/s10753-014-9892-3
  28. Noh G, 2011, ALLERGY ASTHMA IMMUN, V3, P168, DOI 10.4168/aair.2011.3.3.168
  29. Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9
  30. SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
  31. Sgnotto FDR, 2018, INT J DERMATOL, V57, P434, DOI 10.1111/ijd.13907
  32. Smaldini PL, 2018, ALLERGY, V73, P885, DOI 10.1111/all.13402
  33. Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718
  34. Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11
  35. Victor JR, 2017, HUM VACC IMMUNOTHER, V13, P507, DOI 10.1080/21645515.2016.1244592
  36. Victor JR, 2014, J IMMUNOL RES, DOI 10.1155/2014/780386
  37. Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39
  38. Vonk MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01230
  39. Yuksek M, 2011, TURKISH J PEDIATR, V53, P532